Amphastar Pharmaceuticals (AMPH) EPS (Basic) (2013 - 2026)
Amphastar Pharmaceuticals (AMPH) posted quarterly EPS (Basic) of $0.14 for Q1 2026, down 73.31% year-over-year from $0.53 in Q1 2025, and down 86.08% quarter-over-quarter from $1.02 in Q4 2025.
Amphastar Pharmaceuticals (AMPH) EPS (Basic) (2013 - 2026) Analysis & Trends
Amphastar Pharmaceuticals' EPS (Basic) history runs 14 years deep, the most recent figure standing at $0.14 for Q1 2026.
- In Q1 2026, EPS (Basic) fell 73.31% year-over-year to $0.14; the TTM figure through Mar 2026 stood at $2.26 (down 24.01% YoY), while the FY2025 annual figure was $2.59, down 21.53% from the prior year.
- EPS (Basic) for Q1 2026 stood at $0.14, down from $1.02 in the prior quarter.
- The five-year high for EPS (Basic) was $1.02 in Q3 2023, with the low at -$3.01 in Q4 2023.
- The 5-year median for EPS (Basic) is $0.56 (2023), against an average of $0.41.
- The sharpest annual moves came in 2022 and 2023: EPS (Basic) soared 522.27% in 2022, then tumbled 530.12% in 2023.
- Amphastar Pharmaceuticals' EPS (Basic) stood at $0.7 in 2022, then sank by 530.12% to -$3.01 in 2023, then soared by 126.05% to $0.78 in 2024, then climbed by 29.86% to $1.02 in 2025, then plunged by 86.08% to $0.14 in 2026.
- Business Quant data shows AMPH's EPS (Basic) at $0.14 in Q1 2026, $1.02 in Q4 2025, and $0.37 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.07 Bn | 39.42 Bn | 2.15 Bn | -0.49 |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | 2.07 |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 0.45 |
| 5 | United Therapeutics | 22.19 Bn | 19.53 Bn | 683.80 Mn | 7.82 |
| 6 | Viatris | 18.68 Bn | 17.79 Bn | 1.46 Bn | -0.10 |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 1.43 |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 0.11 |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | - |
| 10 | Amphastar Pharmaceuticals | 933.76 Mn | 643.64 Mn | 93.47 Mn | 0.70 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 0.70 |
| Mar 31, 2026 | 0.14 |
| Dec 31, 2025 | 1.02 |
| Sep 30, 2025 | 0.37 |
| Jun 30, 2025 | 0.66 |
| Mar 31, 2025 | 0.53 |
| Dec 31, 2024 | 0.78 |
| Sep 30, 2024 | 0.83 |
| Jun 30, 2024 | 0.78 |
| Mar 31, 2024 | 0.91 |
| Dec 31, 2023 | -3.01 |
| Sep 30, 2023 | 1.02 |
| Jun 30, 2023 | 0.55 |
| Mar 31, 2023 | 0.56 |
| Dec 31, 2022 | 0.70 |
| Sep 30, 2022 | 0.33 |
| Jun 30, 2022 | 0.36 |
| Mar 31, 2022 | 0.52 |
| Dec 31, 2021 | 0.42 |
| Sep 30, 2021 | 0.64 |